4-Nitrofenil-alfa-L-fucopiranósido, mínimo 98 %, para bioquímica, 100 mg, envase de vidrio

(S)-3-((tert-Butoxycarbonyl)amino)-3-(3-(trifluoromethyl)phenyl)propanoic acid, 95.0%, 1g

TRANS-(3-FLUOROCYCLOPENTYL)METHANAMINE HCL, 95.0%, 100mg

Ethyl 2-(1-Benzylpiperidin-4-ylidene)acetate, 97.0%, 10g

1,1,3,3-tetraethoxypropane, 95.0%, 100g

Cefaclor monohydrate, 95.0%, 25g

5-(4-Chlorophenyl)-6-ethylpyrimidine-2,4-diamine, 95.0%, 250mg

N,N-Dimethylformamide di-tert-butyl acetal, 95.0%, 1g

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,3-dichlorophenyl)propanoic acid, 97%, 100mg

2-(3-Methylphenoxy)acetamide, 95+%, 500g

2-hydrazino-1-methyl-1H-benzimidazole hydrochloride, 95.0%, 1g

(4-(2-Phenyl-1H-benzo[d]imidazol-1-yl)phenyl)boronic acid, 95.0%, 25g

(S)-1,1-DIMETHYLTETRAHYDRO-1H-OXAZOLO[3,4-A]PYRAZIN-3(5H)-ONE HCL, 95.0%, 250mg